ACR 2.82% 6.9¢ acrux limited

Ann: Appendix 4D and Half Year Accounts, page-7

  1. 7,510 Posts.
    lightbulb Created with Sketch. 6764
    That's standard accrual accounting, not the company.

    Sales and other revenue broken down easily enough, and importantly the big one API Sales Revenue:

    https://hotcopper.com.au/data/attachments/5993/5993367-50294157b5522844d4aa948b991fce75.jpg


    "Under the terms of the commercialisation agreement with Padagis, Acrux is currently responsible for the procurement of the Active Pharmaceutical Ingredients (‘API’) which are used in the commercial manufacture of Prilocaine 2.5% and Lidocaine 2.5%, Cream. These API purchases are recorded as Cost of Goods Sold and are in turn invoiced to Padagis and are included as Sales Revenue. The increased value of purchases and sales of Prilocaine and Lidocaine API reflect the increase in manufacturing activity relative to the prior comparative period, when the API had been purchased for the manufacture of launch stocks."


 
watchlist Created with Sketch. Add ACR (ASX) to my watchlist
(20min delay)
Last
6.9¢
Change
-0.002(2.82%)
Mkt cap ! $20.05M
Open High Low Value Volume
7.5¢ 7.5¢ 6.9¢ $31.16K 433.1K

Buyers (Bids)

No. Vol. Price($)
1 54422 6.9¢
 

Sellers (Offers)

Price($) Vol. No.
7.2¢ 147301 2
View Market Depth
Last trade - 15.53pm 28/06/2024 (20 minute delay) ?
ACR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.